TipRanks
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market
4886
ASKA Pharmaceutical Holdings Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4886 full AI Analyst Report?

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Ratios

0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Ratios

JP:4886's free cash flow for Q1 2026 was ¥0.47. For the 2026 fiscal year, JP:4886's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 2.89 2.76 2.54 2.34 3.05
Quick Ratio
 1.42 1.45 1.39 1.49 2.04
Cash Ratio
 0.36 0.45 0.46 0.57 0.82
Solvency Ratio
 0.20 0.24 0.22 0.35 0.23
Operating Cash Flow Ratio
 0.00 0.28 0.11 0.06 0.19
Short-Term Operating Cash Flow Coverage
 0.00 1.93 0.56 0.30 0.97
Net Current Asset Value
¥ 24.74B¥ 25.86B¥ 23.99B¥ 27.33B¥ 21.15B
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.10 0.11 0.10 0.14
Debt-to-Equity Ratio
 0.17 0.16 0.17 0.15 0.23
Debt-to-Capital Ratio
 0.14 0.14 0.14 0.13 0.19
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.09 0.07 0.14
Financial Leverage Ratio
 1.55 1.60 1.58 1.47 1.60
Debt Service Coverage Ratio
 1.29 2.16 1.44 2.04 2.13
Interest Coverage Ratio
 29.63 26.28 104.57 162.50 102.16
Debt to Market Cap
 0.19 0.17 0.17 0.16 0.38
Interest Debt Per Share
 422.80 410.65 386.39 336.42 448.78
Net Debt to EBITDA
 0.69 0.15 0.04 -0.34 -0.22
Profitability Margins
Gross Profit Margin
47.42%48.01%48.86%48.80%47.28%
EBIT Margin
7.15%8.20%8.31%15.76%8.94%
EBITDA Margin
9.67%12.54%11.82%20.00%14.11%
Operating Profit Margin
7.15%8.20%8.31%10.34%8.45%
Pretax Profit Margin
8.60%9.83%9.65%15.69%8.86%
Net Profit Margin
6.65%7.63%7.95%12.01%7.01%
Continuous Operations Profit Margin
6.79%7.91%7.95%12.01%7.01%
Net Income Per EBT
77.36%77.60%82.38%76.51%79.11%
EBT Per EBIT
120.25%119.83%116.11%151.72%104.87%
Return on Assets (ROA)
4.29%4.84%4.94%8.31%4.86%
Return on Equity (ROE)
6.82%7.75%7.81%12.18%7.77%
Return on Capital Employed (ROCE)
5.62%6.50%6.64%9.73%7.35%
Return on Invested Capital (ROIC)
4.25%5.05%5.18%6.93%5.54%
Return on Tangible Assets
4.65%5.26%5.30%8.59%5.13%
Earnings Yield
7.65%8.10%7.81%12.34%12.62%
Efficiency Ratios
Receivables Turnover
 4.29 4.46 4.25 4.03 3.97
Payables Turnover
 5.34 4.89 3.59 4.37 11.23
Inventory Turnover
 1.28 1.27 1.25 1.58 1.80
Fixed Asset Turnover
 3.73 3.70 3.43 5.58 5.60
Asset Turnover
 0.64 0.63 0.62 0.69 0.69
Working Capital Turnover Ratio
 1.85 1.91 1.90 1.84 1.74
Cash Conversion Cycle
 302.50 295.29 277.11 238.48 261.89
Days of Sales Outstanding
 85.18 81.88 85.87 90.48 91.86
Days of Inventory Outstanding
 285.62 288.01 293.01 231.42 202.53
Days of Payables Outstanding
 68.30 74.59 101.77 83.43 32.50
Operating Cycle
 370.80 369.88 378.88 321.91 294.39
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 222.06 87.66 52.48 118.67
Free Cash Flow Per Share
 0.00 132.26 -16.76 1.17 92.25
CapEx Per Share
 0.00 89.80 104.42 51.32 26.42
Free Cash Flow to Operating Cash Flow
 0.00 0.60 -0.19 0.02 0.78
Dividend Paid and CapEx Coverage Ratio
 0.00 1.51 0.59 0.66 2.80
Capital Expenditure Coverage Ratio
 0.00 2.47 0.84 1.02 4.49
Operating Cash Flow Coverage Ratio
 0.00 0.55 0.23 0.16 0.27
Operating Cash Flow to Sales Ratio
 0.00 0.09 0.04 0.02 0.06
Free Cash Flow Yield
0.00%5.60%-0.73%0.05%7.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.07 12.35 12.80 8.11 7.92
Price-to-Sales (P/S) Ratio
 0.87 0.94 1.02 0.97 0.56
Price-to-Book (P/B) Ratio
 0.87 0.96 1.00 0.99 0.62
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 17.84 -137.50 1.85K 12.89
Price-to-Operating Cash Flow Ratio
 0.00 10.63 26.28 41.15 10.02
Price-to-Earnings Growth (PEG) Ratio
 -1.82 1.99 -0.39 0.10 -10.51
Price-to-Fair Value
 0.87 0.96 1.00 0.99 0.62
Enterprise Value Multiple
 9.67 7.66 8.66 4.53 3.71
Enterprise Value
 66.32B 68.29B 65.61B 56.90B 31.69B
EV to EBITDA
 9.67 7.66 8.66 4.53 3.71
EV to Sales
 0.94 0.96 1.02 0.91 0.52
EV to Free Cash Flow
 0.00 18.19 -138.13 1.72K 12.17
EV to Operating Cash Flow
 0.00 10.84 26.40 38.29 9.46
Tangible Book Value Per Share
 2.42K 2.38K 2.19K 2.09K 1.77K
Shareholders’ Equity Per Share
 2.49K 2.47K 2.30K 2.19K 1.93K
Tax and Other Ratios
Effective Tax Rate
 0.21 0.20 0.18 0.23 0.21
Revenue Per Share
 2.50K 2.51K 2.26K 2.22K 2.14K
Net Income Per Share
 165.97 191.13 179.95 266.49 150.08
Tax Burden
 0.77 0.78 0.82 0.77 0.79
Interest Burden
 1.20 1.20 1.16 1.00 0.99
Research & Development to Revenue
 0.07 0.10 0.11 0.08 0.07
SG&A to Revenue
 0.33 0.30 0.30 0.21 0.22
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.16 0.49 0.20 0.63
Currency in JPY